• About Ramot
    • Who We Are
    • Our Mission
    • Our Team
    • Board of Directors
    • Funding Opportunities
    • Business Strategies
  • Success Stories
  • Media Center
    • News & Events
    • Newsletters
    • Press Releases
    • Images
      • Biomed 2012
      • Nano Israel 2012
      • Researchers Seminar Feb 2011
      • Watec 2011
    • Movies
      • Technologies Videos
  • Members
    • Get Updates by E-mail
    • Get updates by RSS
  • Contact us
    • Contact Form
My Briefcase (0)

ramot

  • AVAILABLE TECHNOLOGIES
  • INDUSTRY
  • TECHNOLOGY DEVELOPMENT
  • FOR FACULTY
  • Agriculture
  • Defence and Security
  • Electronics and Electro-Optics
  • Environmental and Cleantech
  • ICT and Media
  • Life Sciences and Biotechnology
  • Material Sciences
  • Mechanical Engineering
  • Medical Devices and Diagnostics
  • Nanotechnology
  • Pharmaceuticals Indications
  • Services
Ramot is Tel Aviv University's (TAU) technology transfer company and its liaison to industry, bringing promising scientific discoveries made at the university to industry's attention. The company provides the legal and commercial frameworks for inventions made by TAU faculty, students and researchers, protecting discoveries with patents and working jointly with industry to bring scientific innovations to the market.
Tata partners with Tel Aviv University to fund leading edge innovations for accelerated commercialization
New Media fund for students
Enstorage Goes Live with A 50 KW, Grid Connected HBr Flow Battery
Galien Israel Fund announcement
EARLY DRUG DISCOVERY CHALLENGES Seminar
Should Human Genes Be Patented?
Engineering and Exact Sciences promising innovations Seminar
Tata Chemicals are seeking new technologies
OrbiMed Invests $5 M in cCam
Prof. Ronit Satchi Fainaro innovative cancer research (Hebrew)
TAU Researchers listed in Top 10 Israeli advances against Alzheimer’s disease
Farming Corals for Collagen
IATI Board Elections
Dr. Boaz Almog "levitates" a superconductor
Dramatic Change in Patient with ALS and MG following Compassionate Use of BrainStorm's NurOwn(TM) Cell Therapy
Shlomo Nimrodi has been appointed as Ramot new CEO
  • © All rights reserved to Ramot
  • Disclaimer
  • Sitemap
בניית אתרים ICS